منابع مشابه
U-500 Regular Insulin
OBJECTIVE To describe the clinical experience and the pharmacokinetics of U-500 regular insulin in severely insulin-resistant obese type 2 diabetic patients. RESEARCH DESIGN AND METHODS Patients requiring >200 units of insulin with A1C levels >8.0% were switched to U-500 regular insulin. For the pharmacokinetic study, fasting subjects received 100 units of U-500 regular insulin subcutaneously...
متن کامل300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
Botulinum toxin is probably the newest addition in the treatment armamentarium for overactive bladder , but, despite its late FDA approval, a significant experience exists in several centers around the world with this type of treatment. Because of its experimental status, the treatment with botulinum toxin is still lacking the much needed standardization, allowing for a great variety when it co...
متن کاملA SINGLE-CHIP BALANCED SIS MIXER FOR 200-300 GHz
The balanced mixer is fabricated on a 2 x 1 mm quartz substrate which contains an RF quadrature hybrid and two SIS mixers. These components are realized in capacitively-loaded coplanar waveguide, which minimizes stray coupling between adjacent components and coupling to undesired modes in the thick quartz substrate. Signal and LO waveguides are coupled to separate ports of the main substrate vi...
متن کاملElastic pd scattering with 200–300 MeV protons
H. Rohdjeß,* W. Scobel, H. O. Meyer, P. V. Pancella, S. F. Pate, M. A. Pickar, R. E. Pollock, B. v. Przewoski, T. Rinckel, F. Sperisen, H. Witała, J. Golak, D. Hüber, H. Kamada, and W. Glöckle I. Institut für Experimentalphysik, Universität Hamburg, D-22761 Hamburg, Germany Department of Physics, Indiana University, Bloomington, Indiana 47405 Western Michigan University, Kalamazoo, Michigan 490...
متن کاملCost Minimization Analysis Of U100 Insulin And U40 Insulin In Egyptian Diabetic Patients.
An intensive information campaign providing detailed advice for patients, physicians and pharmacists is essential for the prevention of medication errors and reduction of overall costs. *Address correspondence to: Andrew Metry Central Administration for Pharmaceutical Affairs, 21 Abd Elaziz Alsoud Street, PO 11451, Elmanial, Cairo, Egypt. Email: [email protected] Web: www.eda.mohealt...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Diabetes
سال: 2016
ISSN: 2397-6241,2397-6233
DOI: 10.15277/bjd.2016.056